Biotech & pharma
Indian Patent Office rejects AbbVie patent bid for cancer drug Venetoclax; generics may enter market
By Cygnus | 23 Jan 2026
The Indian Patent Office rejected AbbVie’s patent application for cancer drug Venetoclax (Venclexta), a decision expected to ease the entry of lower-cost generics.
Sun Pharma Weighs $10 Billion Takeover of Organon to Expand US Footprint
By Cygnus | 19 Jan 2026
Sun Pharma is evaluating a ~$10B acquisition of Organon to expand its U.S. footprint in women's health and biosimilars, according to reports.
The $280 Ozempic: How a Canadian Bridge to India is Slashing U.S. Weight-Loss Costs
By Axel Miller | 07 Jan 2026
U.S. patients are bypassing $1,100 retail prices with $280 India-sourced Ozempic pens via Canada. A deep dive into the 2026 semaglutide supply chain.
Glenmark Pharma Hits Record High on Landmark AbbVie Licensing Deal
By Cygnus | 11 Jul 2025
Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a significant licensing agreement with U.S. drugmaker AbbVie.
India achieves breakthrough in gene therapy for Haemophilia
25 Apr 2025
Bengaluru’s BRIC-inStem institute has achieved a breakthrough in gene therapy for Haemophilia, union minister for science and technology, Dr Jitendra Singh said
Bayer seeks legal cover in US for its Roundup weedkiller sales
08 Mar 2025
German pharmaceutical and biotechnology group, Bayer, has told the US government that it would have to stop selling its Roundup weedkiller in the United States
Balrampur Chini sets up India's first biopolymer manufacturing unit in Uttar Pradesh
24 Feb 2025
Balrampur Chini Mills Ltd (BCML), one of the largest sugar mills in the country, is diversifying further by venturing into the production of Poly Lactic Acid (PLA)
Scientists at Mohali’s Nano Science Institute identify common biomarker for cancer detection
21 Feb 2025
A research team at the Institute of Nano Science and Technology (INST), Mohali has identified a common biomarker for early detection of a range of cancers
.webp)
PM Modi hails Genome project as data of 10,000 Indians go live
09 Jan 2025
Prime Minister Narendra Modi on Thursday announced the completion of the Genome India project, which makes available database of 10,000 Indians
Pune’s Agarkar Institute develops novel molecule for treating Alzheimer’s disease
26 Oct 2024
Scientists from Agharkar Research Institute, Pune, an autonomous institute of Department of Science and Technology,
Victor Ambros and Gary Ruvkun of US win Medicine Nobel for discovery of microRNA
08 Oct 2024
Victor Ambros, a professor at the Harvard Medical School and Gary Ruvkun, an investigator with Massachusetts General Hospital, jointly won the 2024 Nobel Prize in Physiology or Medicine.
Western drugmakers pivot to India as tensions with China prompt supply chain shifts
27 Nov 2023
In a strategic move to reduce dependence on Chinese contractors in drug production, global pharmaceutical companies are turning to Indian manufacturers.
British Airways joins Project Speedbird for cleaner aviation fuel
17 Nov 2023
The project is supported by the British government with a £9 million grant from the Advanced Fuels Fund (AFF).
Merck and Daiichi partner on a $5.5 billion deal for cancer therapy development
20 Oct 2023
The American pharmaceutical company Merck will start a joint venture with Daiichi Sankyo to develop three of its candidate cancer drugs.
U.S. pharmacy store Rite Aid files for bankruptcy protection amid several lawsuits
16 Oct 2023
Rite Aid filed for Chapter 11 bankruptcy on Sunday, October 15, 2023, taking a step to suspend the lawsuits against the drugstore chain related to its alleged
CRISIL predicts an 8-10% revenue growth for Indian pharma industry in current fiscal year
11 Sep 2023
According to a report, the Indian pharmaceutical industry is expected to achieve 8 to 10 per cent revenue growth in the current fiscal year.
Accusations from Iowa farmers: China allegedly stealing American seeds
08 Aug 2023
Farmers in Iowa are making accusations against the Chinese state, alleging the theft of invaluable seed samples from America.
US scientists create 'living robots' that can reproduce themselves
01 Dec 2021
With the help of artificial intelligence, the researchers have found that the Xenobots are able to find tiny stem cells in a petri dish, gather hundreds of them inside their mouth, and bundle them out as new Xenobots in a few days
Latest articles
.webp)
Featured articles
The New Airspace Economy: How Geopolitics Is Rewriting Aviation Costs in 2026
By Axel Miller | 22 Jan 2026
Airspace bans, sanctions and corridor risk are forcing airlines into costly detours in 2026, raising fuel burn, reducing aircraft utilisation and pushing airfares higher worldwide.
India’s Data Center Arms Race: The Battle for Power, Cooling, and AI Real Estate
By Cygnus | 22 Jan 2026
India’s data centre boom is turning into an AI arms race where power contracts, liquid cooling and fast commissioning decide the winners across Mumbai, Chennai and Hyderabad.
India’s Oil Balancing Act: Refiners Rebuild Middle East Supply Lines as Russia Flows Disrupt
By Axel Miller | 21 Jan 2026
India’s refiners are rebalancing crude sourcing as Russian imports fell to a two-year low in December 2025, lifting OPEC’s share and raising geopolitical risk concerns.
Arctic Fever: How ‘Greenland Tariff’ Politics Sparked a Global Flight to Safety
By Axel Miller | 20 Jan 2026
Greenland-linked tariff threats have injected fresh uncertainty into transatlantic trade, triggering a risk-off shift in markets and reshaping global supply chain planning.
The New Oil (Part 5): Friend-Shoring, Supply Chain Fragmentation and the Cost of Resilience
By Cygnus | 19 Jan 2026
Friend-shoring is reshaping lithium, rare earth and graphite supply chains, creating a resilience premium and new winners and losers in clean tech.
The New Oil (Part 4): Can Technology Break the Dependency?
By Cygnus | 16 Jan 2026
Can magnet recycling and rare-earth-free motors reduce global dependence on strategic minerals? Part 4 explores breakthroughs, limits and timelines.
India’s Gig Economy Reset: The End of ‘10-Minute Delivery’ Hype?
By Cygnus | 14 Jan 2026
India’s quick-commerce sector is shifting away from “10-minute delivery” hype amid worker safety concerns and rising regulation. Here’s what changes—and what doesn’t.
AI Is Becoming the New Electricity Crisis: Why the Real Bottleneck Is Megawatts
By Axel Miller | 14 Jan 2026
AI is turning into an electricity crisis as data centres scale from chips to megawatts. Grid bottlenecks, copper demand and cooling limits are now the real AI constraints.
The New Oil (Part 3): Can Technology End the Rare Earth Dependency?
By Cygnus | 14 Jan 2026
Magnet recycling and rare-earth-free motors are emerging as technology escape routes from critical mineral dependency. But timelines are slower than the hype suggests.
